CuraSen Therapeutics Presents Phase 1b Clinical Data with CST-103 Demonstrating Significant Increases in Cerebral Blood Flow in Patients with Mild Cognitive Impairment or Parkinson’s Disease by Seini Moimoi | Nov 9, 2021 | Portfolio News
Aptinyx Reports Third Quarter 2021 Financial Results and Recent Highlights by Seini Moimoi | Nov 9, 2021 | Portfolio News
Tricida Announces Third Quarter 2021 Financial Results by Seini Moimoi | Nov 8, 2021 | Portfolio News
Aimmune Therapeutics to Present New Data at ACAAI on the Real-World Burden of Peanut Allergy and Early Physician Experience with PALFORZIA® in Clinical Practice in the U.S. by Seini Moimoi | Nov 5, 2021 | Portfolio News
